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Protection of neonatal Mice from an 
extracellular Bacterial 
enteropathogen
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Immunology, University of Miami Miller School of Medicine, Miami, FL, USA
Both human and murine neonates are characteristically highly susceptible to bacterial 
infections. However, we recently discovered that neonatal mice are surprisingly highly 
resistant to oral infection with Yersinia enterocolitica. This resistance was linked with 
activation of both innate and adaptive responses, involving innate phagocytes, CD4+ 
cells, and B cells. We have now extended these studies and found that CD8+ cells also 
contribute importantly to neonatal protection from Y. enterocolitica. Strikingly, neonatal 
CD8+ cells in the mesenteric lymph nodes (MLN) are rapidly mobilized, increasing in 
proportion, number, and IFNγ production as early as 48 h post infection. This early 
activation appears to be critical for protection since B2m−/− neonates are significantly 
more susceptible than wt neonates to primary Y. enterocolitica infection. In the absence 
of CD8+ cells, Y. enterocolitica rapidly disseminated to peripheral tissues. Within 48 h 
of infection, both the spleens and livers of B2m−/−, but not wt, neonates became 
heavily colonized, likely leading to their deaths from sepsis. In contrast to primary 
infection, CD8+ cells were dispensable for the generation of immunological memory 
protective against secondary infection. These results indicate that CD8+ cells in the 
neonatal MLN contribute importantly to protection against an extracellular bacterial 
enteropathogen but, notably, they appear to act during the early innate phase of the 
immune response.
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inTrODUcTiOn
Neonates and infants are commonly highly susceptible to infectious diseases. Many of these diseases 
are caused by bacterial pathogens, which are largely naturally acquired by oral ingestion. Because of 
the many similarities in immunity in early life between mice and humans (1, 2), neonatal mice pro-
vide a reasonably faithful and experimentally convenient model system for studying infection with 
bacterial enteropathogens. Indeed, as in humans, mouse neonates are very sensitive to oral infection 
with a number of bacterial enteropathogens, including Salmonella typhimurium (3, 4), Helicobacter 
pylori (5–7), Shigella flexneri (8–10), Vibrio cholera (11, 12), and the Enteropathogenic E. coli-related 
Citrobacter rodentium (13–16). Often, these susceptibilities are linked to quantitative or qualitative 
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differences in neonatal and adult responses involving both the 
innate and adaptive gastrointestinal immune systems.
In contrast to all other descriptions of infections in neonatal 
mice, our laboratory found that 7-day-old murine neonates are 
highly resistant to orogastric infection with the extracellular 
enteropathogen Yersinia enterocolitica (17). Y. enterocolitica dis-
seminates to the mesenteric lymph nodes (MLN), and analyses 
of immune function in that site revealed robust responses involv-
ing both the innate and adaptive arms of immunity (18, 19). 
Proinflammatory cytokine gene expression was highly induced, 
and innate phagocytes infiltrated the MLN in high numbers. 
Mature or supra-mature adaptive responses were also detected. 
We demonstrated that CD4 cell Th1 and Th17 function were both 
critical for protection of neonates and serum antibody responses 
of similar magnitude and avidity to those in adults were observed. 
Finally, and strikingly, neonates developed protective immunity 
against subsequent exposure as adults to a lethal dose of the 
bacterium.
These results indicated that protective responses against 
Y. enterocolitica in early life involve multiple innate and adaptive 
cell types. In these initial experiments, we largely ignored CD8 
cells since these cells are more commonly associated with viral or 
intracellular bacterial infections. However, in the course of these 
studies, we noted that a large proportion of CD8 cells in the MLN 
of uninfected neonates expressed the proliferative antigen Ki67. 
Upon infection, CD8+, but not CD4+ cells, increased rapidly in 
proportion and IFNγ production. B2m−/− neonates were more 
susceptible to infection, compared with wt neonates, indicating 
that CD8+ cells were required for survival of primary infection. 
The susceptibility of B2m−/− neonates was linked to the early dis-
semination of the bacteria to peripheral organs. Last, although 
required for primary infection, CD8+ cells were dispensable 
for survival of secondary infection. These results indicate that 
neonatal CD8+ cells may play an important early, innate-like role 
in survival to primary infection with Y. enterocolitica but they 
are not necessary for the development of protective memory in 
neonates.
MaTerials anD MeThODs
Mice
Adult C57BL/6 and B2m-deficient mice (B6.129P2-B2mtm1-Unc/J) 
were purchased from Jackson Laboratories. All mice were bred 
and housed under barrier conditions in the Division of Veterinary 
Resources of the University of Miami Miller School of Medicine. 
Mice were regularly screened for specific common pathogens. 
Adult mice (6–10 weeks of age) and neonatal mice (7 days of age) 
were used in experiments. All mice were handled in compliance 
with the Institutional Animal Care and Use Committee (IACUC) 
of the University of Miami Miller School of Medicine, Miami, 
FL, USA.
Bacterial infections
Wild-type high-virulence Y. enterocolitica A127/90 serotype 
0:8 biotype IB was originally provided by G. R. Cornelis 
(Universität Basel, Basel, Switzerland). For infection, bacterial 
frozen stocks (17) were washed twice with Hank’s Balanced 
Salt Solution (HBSS, Gibco, Grand Island, NY, USA), diluted 
to the desired concentration, and inoculated with the indicated 
doses. Adults were inoculated orogastrically with a 22-gauge, 
round-tipped feeding needle (Fine Science Tools, Foster City, 
CA, USA) attached to a 1-ml syringe (Becton Dickinson, 
Franklin Lakes, NJ, USA). Neonates were inoculated orogastri-
cally with PE-10 tubing (polyethylene tubing with an outside 
diameter of 0.61 mm) (Clay Adams, Sparks, MD, USA) attached 
to a 30-gauge needle and Hamilton syringe (20). The actual 
administered dose was determined by plating serial dilutions 
of the suspensions on Luria Broth plates and incubating for 
48 h at 27°C.
cell staining, antibodies, and  
Flow cytometry analysis
Individual MLN from neonates and adults were harvested and 
placed in cold HBSS containing 1% calf serum (Gibco), 10 mM 
HEPES (Gibco), and 4  mM sodium azide. Cell suspensions 
were prepared by mincing tissues with scissors and pressing 
cells through wire mesh with 74 µm pore size (Compass Wire, 
Westville, NJ, USA). Cells were incubated in mouse Fc Block 
(CD16/CD32; BD Pharmingen, San Diego, CA, USA) for 5 min 
on ice, followed by a 30-min incubation with fluorochrome-
conjugated antibodies specific for CD4, CD8, Ki67, or TCRαβ 
(BD Pharmingen). For intracellular cytokine staining, cells 
were activated with 50 ng/ml PMA and 0.5 µM ionomycin in 
the presence of 5 µg/ml brefeldin A, fixed and permeabilized, 
and stained with fluorochrome-conjugated anti-IFNγ (BD 
Pharmingen). Samples were run on a Becton Dickinson LSR 
II flow cytometer and analyzed with FlowJo flow cytometry 
analysis software.
Bacterial enumeration from  
Organs of infected Mice
To measure Y. enterocolitica titers, tissues were weighed and 
homogenized in HBSS using a Seward Biomaster 80 Stomacher 
(Brinkman, Westbury, NY, USA) for 4  min at high speed. For 
small intestine mucosa-associated Y. enterocolitica titers, the small 
intestine contents were flushed with HBSS prior to homogeniza-
tion. Individual MLN were homogenized in 400 μl (neonates) or 
500 μl (adults) of HBSS using a VWR disposable pellet mixer 
with cordless motor (VWR International). Y. enterocolitica titers 
were enumerated by plating dilutions of homogenates on Difco 
Yersinia Selective Agar Base plates (Becton Dickinson, Sparks, 
MD, USA).
statistical analyses
All experiments were performed at least two times. Statistical 
tests were performed using GraphPad Prism software, as follows: 
unpaired t test for the Ki67/CD4/CD8/IFNγ staining experi-
ments; Mann–Whitney test for the bacterial colonization experi-
ments; Log-rank (Mantel–Cox) test for the survival experiments. 
The significant threshold was P ≤ 0.05.
FigUre 1 | neonatal Tcrβ+cD8+ cells in the mesenteric lymph nodes (Mln) are cycling in uninfected animals and rapidly increase in response to 
infection with Yersinia enterocolitica. (a) Representative profile of MLN cells from uninfected 7-day-old or adult mice stained for TCRβ, CD4, CD8, and Ki67.  
(B) The percentages of Ki67+ among TCRβ+CD4+ or TCRβ+CD8+ cells in uninfected individual neonatal or adult MLN. (c) The percentages of TCRβ+CD4+ or 
TCRβ+CD8+ MLN cells in individual mice 1 day post infection with 5 × 108 CFU Y. enterocolitica.
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resUlTs
rapid responses of neonatal Mln cD8+ 
cells following Oral Y. enterocolitica 
infection
In the course of characterizing immune responses to Y. enterocol-
itica infection, we compared MLN cells from uninfected neonates 
and adults for expression of the proliferation antigen Ki67. 
Approximately 10% of both CD4+ and CD8+ cells in adult MLN 
expressed the Ki67 antigen. A much greater proportion of both 
T cell types were Ki67+ in neonatal MLN (Figures 1A,B). This 
is consistent with previous studies in which neonatal T cells in 
mouse spleen and cord blood were found to be spontaneously 
proliferating at a higher rate than in adults (21, 22). However, the 
frequency of proliferating cells in the MLN, especially among the 
CD8+ population, is markedly higher than in blood or spleen.
The substantial endogenous proliferation of CD8+ cells 
in uninfected neonates indicated that this population may 
pre-exist in a state poised for rapid responsiveness to invasive 
intestinal pathogens. Indeed, within 24  h of infection with 
Y. enterocolitica, there was a significant increase in the propor-
tion of neonatal CD8+ cells while percentages of neonatal CD4+ 
and adult CD4+ and CD8+ did not increase (Figure  1C). The 
absolute numbers showed a similar pattern, although neonatal 
CD4+ cells also increased by fivefold while CD8+ cell numbers 
increased eightfold. Neither population increased in absolute 
numbers in adults.
These results indicated that the neonatal CD8+ population was 
able to expand rapidly in response to Y. enterocolitica infection. 
The next question was whether this expansion was accompanied 
by effector function. A prominent effector function of CD8+ 
cells is the production of IFNγ. Our previous studies had shown 
that IFNγ is required for survival of neonates to Y. enterocolitica 
infection (18) and that IFNγ production by CD4+ cells was an 
important component of protection. However, IFNγ-producing 
CD4+ cells most likely act in the later stages of primary infec-
tion, during the adaptive phase of the response, since death in 
CD4-deficient neonates is delayed until ≥15 days post infection. 
In striking contrast, IFNγ-deficient neonates die rapidly, within 
7 days of infection. Together, these results suggest that IFNγ may 
provide important protection both early and late post infection. 
Thus, we proposed that early activated CD8+ cells may be a 
rapid source of IFNγ production. We first examined early IFNγ 
production among total MLN cells and found an increase in total 
cytokine-producing cells in neonates, but not adults (Figure 2A). 
Indeed, a significant increase in IFNγ-production was selectively 
observed in the neonatal CD8+ population (Figure  2B). Thus, 
Y. enterocolitica infection of neonates is characterized by the rapid 
mobilization of CD8+ MLN populations with IFNγ-producing 
effector function.
neonatal cD8+ cells are essential  
for survival to Primary infection and for 
Preventing early systemic Dissemination 
of Y. enterocolitica
Our results thus far indicated that neonates infected with 
Y. enterocolitca mount early CD8+ responses. To test whether CD8+ 
cells were essential for protection against infection, survival of wt 
and B2m−/− neonates to a threshold lethal dose of Y. enterocolitica 
was compared. As shown in Figure 3, B2m−/− neonates were more 
susceptible to lethal infection and, notably, most deaths occurred 
prior to 14  days post infection—i.e., well before the time that 
CD4−/− neonates begin to succumb (18). In these experiments, 
we used female and male neonates indiscriminately but subset 
analyses showed that there were no differences in survival of male 
or female neonates in either wt or B2m−/− neonates. Therefore, 
CD8+ cells appear to play an important role in the survival of 
neonates, regardless of gender.
Yersinia enterocolitica replicates in the small intestines and 
routinely invades to the MLN but only systemically disseminates 
FigUre 3 | cD8+ cells are critical for survival of neonatal mice to 
primary Yersinia enterocolitica infection. The 7-day-old wt or B2m−/− 
pups were orally infected with 1 × 107 CFU Y. enterocolitica and survival was 
monitored. A total of 33 wt and 27 B2m−/− pups was analyzed in ≥3 separate 
experiments. P = 0.0004 in the Log-rank (Mantel–Cox) test.
FigUre 2 | rapid increase in the percentages of Tcrβ+cD8+ cells producing iFnγ in neonatal mesenteric lymph nodes (Mln) after infection with 
Yersinia enterocolitica. Neonatal and adult mice were infected with 5 × 108 CFU Y. enterocolitica. Forty-eight hours later, MLN cells were prepared, stimulated 
with PMA + ionomycin, in the presence of brefeldin A, for 4 h, and then subjected to intracellular cytokine staining. (a) Frequencies of IFNγ+ cells among total lymph 
node cells in uninfected and infected neonatal and adult animals. Gates for IFNγ were determined by comparison with isotype-matched control stains. (B) The 
frequencies of IFNγ-producing cells within the TCRβ+CD4+ or TCRβ+CD8+ populations. Each point for neonates represents a pool of 2–4 animals; a total of eight 
neonates were examined. Each point for adults represents an individual animal. Differences between uninfected and infected animals are non-significant unless 
indicated with *.
4
Siefker and Adkins Neonatal CD8 Cell Antibacterial Defense
Frontiers in Pediatrics | www.frontiersin.org January 2017 | Volume 4 | Article 141
if the dose of infection is very high in wt animals or if animals are 
immunocompromised (23). Significant systemic dissemination 
most likely leads to death via septic shock. To investigate the 
potential importance of CD8+ cells in confining Y. enterocolitica 
to the intestinal tissues, we compared early colonization of intes-
tinal and systemic organs in infected wt and B2m−/− neonates. 
48 h post infection, colonization levels of the small intestines and 
MLN were similar in wt and B2m−/− neonates (Figures 4A,B). 
However, at this relatively early time point, both the liver and 
spleen showed massive bacterial infiltration only in the B2m−/− 
neonates (Figures  4C,D). These results indicate that the early 
activation of CD8+ cells in the neonatal MLN may be critical for 
preventing the systemic spread of Y. enterocolitica.
Protective Memory responses are 
generated in neonates in the absence of 
cD8+ cells
In adult mice, CD8+ cells appear to be essential for protection 
against secondary infection with the closely related bacterium 
Yersinia pseudotuberculosis (24). To test whether this was also the 
case in neonates, B2m−/− neonates were infected with a sublethal 
dose (1 ×  104  CFU) of Y. enterocolitica. Uninfected littermates 
were kept as control mice. Eight weeks later, all mice were chal-
lenged with 1 ×  105  CFU of Y. enterocolitica, and survival was 
monitored. At this challenge dose, approximately 50% of the con-
trol, previously uninfected, mice survived (Figure 5). However, 
100% of the B2m−/− mice previously infected as neonates survived 
the infection. Therefore, CD8+ cells are not required for either the 
development of immunological memory in neonates or for its 
manifestation in response to secondary challenge.
DiscUssiOn
The results presented here demonstrate that CD8+ cells are 
critical for protection of neonates against oral exposure to an 
FigUre 5 | neonatal mice develop protective memory responses in 
the absence of cD8+ cells. 7-day-old B2m−/− mice were infected with 
1 × 104 CFU Yersinia enterocolitica. Eight weeks later, the mice were 
challenged with 1 × 105 CFU Y. enterocolitica; in parallel, naïve age-matched 
B2m−/− controls were similarly challenged. A total of 6 pre-infected and 20 
naïve mice were analyzed in two separate experiments. P = 0.0239, using 
the Log-rank (Mantel–Cox) test.
FigUre 4 | enhanced early dissemination to peripheral tissues in 
B2m−/− neonates. 7-day-old wt and B2m−/− pups were orally infected with 
5 × 108 CFU Yersinia enterocolitica, and CFU in (a) small intestines (minus 
contents) (SI), (B) mesenteric lymph nodes (MLN), (c) liver (LIV), and (D) spleen 
(SP) were measured 48 h post infection. Each point represents an individual 
mouse; the dashed lines indicate the limits of detection in each assay.
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extracellular bacterial enteropathogen. The protective effects 
appear to manifest early after infection since CD8+ cells in the 
MLN selectively increase within 24 h of infection and over ¼ of 
the cells are producing IFNγ just 48 h post infection. Moreover, 
CD8+ cells appear to be important for the early containment of 
bacteria within the intestines; the spleens and livers of B2m−/− 
neonates were heavily colonized by bacteria as early as 48  h 
post infection. Therefore, unlike in their typical adaptive role, 
neonatal CD8+ cells in intestinal lymphoid tissues act during the 
early, innate phase of the response, providing an important rapid 
antibacterial function.
CD8+ cell function in neonates has been mostly studied in 
response to infection with viruses, including influenza virus (25, 
26), herpes simplex virus (27–29), respiratory syncytial virus 
(30), cytomegalovirus (31, 32), lymphocytic choriomeningitis 
virus (33), adenovirus (34), and Cas-Br-E murine leukemia virus 
(35–37). Most often, these viruses have been introduced either 
systemically or through a pulmonary route. Common, although 
not exclusive, observations are that the CD8 cell response is 
delayed relative to that of adults, lytic and/or IFNγ-secreting 
activities are diminished, the repertoire appears to be limited, and 
neonatal CD8+ memory responses are poor. In all cases, however, 
neonatal CD8+ cell activity was measured during the adaptive 
phase of the response. There are far fewer studies on neonatal 
CD8 cell function in response to bacterial infection and those 
are limited to systemic infection of neonates with the intracel-
lular pathogen Listeria monocytogenes (38, 39). Thus, we believe 
that the neonatal response to Y. enterocolitica represents the first 
description of neonatal CD8+ cells acting in a protective manner 
during the innate phase of the response against an extracellular 
bacterial enteropathogen.
Although CD8 cells had not previously been implicated in 
enterobacterial infection in neonates, a role for these cells in adult 
Yersinia infection has been described (24). Like our observations 
in neonates, it was reported that oral infection with Y. pseudo-
tuberculosis led to increased colonization of peripheral tissues 
in B2m−/− adults. However, we found rapid (≤48  h) increased 
colonization in neonatal B2m−/− mice whereas the increase in 
adults was not detected until 14 days post inoculation, during 
the adaptive phase of immunity. In addition, we found that 
CD8 cells were not required for protective memory responses 
whereas in adults, anti-CD8 treatment greatly compromised 
memory responses. Overall, while CD8 cells may contribute to 
immunity against Yersinia infection in both neonates and adults, 
the roles these cells play and when they act differ in early life and 
adulthood.
The mechanisms underlying the early responses of neonatal 
CD8 cells in Yersinia enterocolitica infection are not yet fully 
understood. One finding that may provide some insight is the 
observation that >50% of neonatal MLN CD8+ cells express 
proliferating antigens in uninfected, resting animals. Due to 
the lymphopenic state of neonates, homeostatic proliferation 
of both CD4+ and CD8+ cells has been previously described in 
neonatal spleen (21) and in human cord blood (22). In both 
cases, as we see here, a greater proportion of CD8+ cells are 
cycling relative to CD4+ cells. However, the percentages of 
CD8+ cells in cycle in the MLN is approximately fivefold higher 
than that in the blood or spleen, perhaps due to the proximity 
of ongoing colonization by the commensal microbiota (40). 
Proliferation in lymphopenic hosts leads to the capacity for 
rapid induction of IFNγ expression (41, 42)—in our case, the 
IFNγ appears to be elicited upon exposure to bacterial enter-
opathogen. In that regard, human neonatal CD8+ cells have 
been shown to rapidly respond to TLR2 or TLR5 stimulation 
with increased proliferation and cytokine production (43), and 
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it is possible that murine neonatal CD8+ cells in the MLN are 
similarly responding to PAMPs expressed by Y. enterocolitica. 
Thus, neonatal CD8 cells may perform both adaptive functions, 
in response to virus or intracellular bacteria, and innate func-
tions when exposed to extracellular pathogens, especially at 
mucosal sites.
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